Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.4096
-0.0329 (-7.44%)
At close: Aug 3, 2026, 4:00 PM EDT
0.4099
+0.0003 (0.07%)
After-hours: Aug 3, 2026, 7:03 PM EDT

Cellyan Biotechnology Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingSep '25 Mar '25 Mar '24 Mar '23
Revenue
16.3620.3116.6912.56
Revenue Growth
-19.46%21.72%32.91%-
Gross Profit
1.442.423.562.74
Operating Income
-0.660.131.611.04
Net Income
-0.7-0.031.331
Earnings Per Share
-0.07-0.000.180.15
EPS Growth
--23.29%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '25 Mar '25 Mar '24 Mar '23
Cash & Investments
2.483.010.620.52
Total Debt
2.272.372.090.69
Net Cash (Debt)
0.210.63-1.47-0.17
Net Cash Growth
-66.92%---
Net Cash Per Share
0.020.06-0.20-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingSep '25 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-0.430.57-0.391.73
Capital Expenditures
-0.06-0.07-0.05-0.11
Free Cash Flow
-0.490.5-0.451.61
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingSep '25 Mar '25 Mar '24 Mar '23
Gross Margin
8.80%11.89%21.32%21.81%
Operating Margin
-4.04%0.65%9.64%8.31%
Pretax Margin
-4.71%0.18%9.14%8.13%
Profit Margin
-4.29%-0.13%7.97%7.95%
FCF Margin
-3.01%2.46%-2.68%12.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Mar '25 Mar '24 Mar '23
P/FCF Ratio
-23.79--
PS Ratio
0.610.58--